| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
2 companies
Allene M. Diaz is Director at IONS and has filed Form 4s across 2 companies. Allene M. Diaz's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $154K at current prices.
Historically, Allene M. Diaz's trades have earned a below-average insider score of 45/100 across 5 rated trades. Over a 12-month horizon, 33.3% of those trades were profitable, with an average 12-month return of -15.3%.
The biggest single holding is IONS (~$154K) as Director. The IONS filings lean toward selling, a net 68,710 shares.
Allene M. Diaz has 22 Form 4 filings on record from March 2021 to July 2026, across 2 companies: Director at Ionis Pharmaceuticals (IONS), 2021–2026; Director at MRSN, 2021–2026.
The 42 reported transactions were 18 option or other derivative awards, 8 option exercises, 8 open-market sales and 6 dispositions back to the company, plus smaller numbers of other types.
Counted by filing, the open-market trades come to no purchases and 5 sales worth about $5.4M.
The largest open-market sale was 54,878 shares of IONS at an average $79.35 on March 3, 2026, about $4.4M.
All 5 sales since April 2023 were made under a Rule 10b5-1 trading plan, set up in advance.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 7, 2026 | IONS Ionis Pharmaceuticals, Inc. | Director | Sale+OE10b5-1 | 10,111 | $85.42 | $863,637.13 | -72.6% | -49.6% | - | |
| Mar 3, 2026 | IONS Ionis Pharmaceuticals, Inc. | Director | Sale+OE10b5-1 | 54,878 | $79.35 | $4,354,428.21 | -93.5% | -4.2% | - | |
| Aug 22, 2025 | IONS Ionis Pharmaceuticals Inc | Director | Sell10b5-1 | 1,427 | $42.53 | $60,687.17 | -7.2% | +71.3% | +39.9% | |
| Jul 16, 2024 | IONS Ionis Pharmaceuticals Inc | Director | Sale+OE10b5-1 | 1,637 | $49.49 | $81,019.40 | -9.4% | -22.5% | -14.2% | |
| Aug 1, 2023 | IONS Ionis Pharmaceuticals Inc | Director | Sell10b5-1 | 657 | $41.05 | $26,969.85 | -4.9% | +6.8% | +20.0% |